CME Group (NASDAQ:CME) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

CME Group (NASDAQ:CME) issued its quarterly earnings data on Wednesday. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03, FiscalAI reports. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.68 EPS.

Here are the key takeaways from CME Group’s conference call:

• Record third-quarter performance: Average daily volume rose 16% year over year to a record 29.4 million contracts, with double-digit growth across all six asset classes. Revenue increased 13% to $1.7 billion, adjusted EPS rose 13% to $3.02, and adjusted operating margin reached 69.4%.
• Client engagement and balance-sheet activity remained strong, with open interest reaching a record 128 million contracts at quarter-end and exceeding 133 million in October. CME said it delivered more than $100 billion per day in average margin savings, supported by growth in portfolio and cross-margining programs.
• Market data revenue grew 20% to a record $243 million, marking the 34th consecutive quarter of year-over-year growth. Management cited rising professional and retail subscriptions, data-feed demand, pricing changes, and sustained market volatility as key drivers.
• Product innovation is broadening CME’s growth opportunities, including Single Stock futures, expanded 24/7 trading, Treasury Link, and planned CME Securities Clearing. Single Stock futures generated more than 350,000 contracts and $3.5 billion in notional value shortly after launch, while Compute Futures received significant client interest but remains subject to regulatory approval.
• Management returned nearly $1 billion to shareholders through dividends and repurchases and retains flexibility for acquisitions, but emphasized a disciplined approach to M&A. Regulatory uncertainty remains around Compute Futures, 24/7 oil trading, and perpetual contracts, while management stressed that broader 24/7 markets may require supporting banking and clearing infrastructure.

CME Group Stock Performance

NASDAQ CME opened at $295.79 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 52-week low of $218.31 and a 52-week high of $329.16. The business’s 50-day moving average price is $276.11 and its 200 day moving average price is $270.49. The firm has a market cap of $106.36 billion, a P/E ratio of 25.09, a P/E/G ratio of 3.80 and a beta of 0.24.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were paid a dividend of $1.30 per share. The ex-dividend date was Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio is 44.11%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: JPMorgan upgrade provides a major catalyst. The firm’s bullish rating reflects increased confidence in CME’s earnings outlook and trading activity. Briefing.com analyst upgrade report
• Positive Sentiment: Third-quarter results exceeded expectations. CME reported $1.74 billion in revenue, up 10.6% year over year and above the $1.71 billion consensus estimate. Adjusted earnings of $3.02 per share also topped the approximately $2.99 estimate, supported by record derivatives volumes and higher transaction fees. CME Group third-quarter earnings release
• Positive Sentiment: Operating momentum remains strong. Average daily volume reached a third-quarter record of 29.4 million contracts, including 9 million contracts outside the United States. Market-data revenue rose 20% to a record $243 million, while CME returned nearly $1 billion to shareholders through dividends and repurchases. CME Group long-term investor takeaways
• Positive Sentiment: New products could broaden future growth. CME outlined a December 7 launch for CME Securities Clearing and continued expansion in cryptocurrency products, including the first UNI futures block trade. Plans for token-related index products and tungsten futures could further diversify activity, subject to regulatory approval. CME Securities Clearing launch report
• Neutral Sentiment: CEO Terry Duffy highlighted record participation, 24/7 energy-contract initiatives and the company’s approach to managing risk, offering additional context on CME’s growth strategy. CNBC interview with CME Group CEO
• Negative Sentiment: Higher expenses limited the earnings reaction. Although revenue and earnings beat forecasts, reports said operating expenses disappointed investors, initially pressuring the stock and tempering the benefit of the results.

Insider Buying and Selling at CME Group

In related news, Director William Shepard purchased 293 shares of the firm’s stock in a transaction that occurred on Friday, September 25th. The stock was purchased at an average cost of $268.76 per share, with a total value of $78,746.68. Following the completion of the acquisition, the director directly owned 263,289 shares in the company, valued at $70,761,551.64. This trade represents a 0.11% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Terrence Duffy sold 15,000 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the transaction, the chief executive officer directly owned 40,630 shares in the company, valued at $11,150,497.20. This represents a 26.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Weiss Ratings upgraded CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. UBS Group boosted their price objective on CME Group from $260.00 to $270.00 and gave the company a “neutral” rating in a report on Monday, October 5th. JPMorgan Chase & Co. raised CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 target price on the stock in a research note on Thursday. Finally, Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Ten equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $300.25.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.